Monday, November 26, 2018
Twist Bioscience initiated at JPMorgan
Twist Bioscience initiated with a Neutral at JPMorgan. JPMorgan analyst Tycho Peterson started Twist Bioscience with a Neutral rating and $27 price target. The analyst prefers to wait for a better entry point with the stock essentially doubling since the initial public offering.
https://thefly.com/landingPageNews.php?id=2827577
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.